Detalhe da pesquisa
1.
Electrocardiographic Diagnosis of Hypertrophic Cardiomyopathy in the Pre- and Post-Diagnostic Phases in Children and Adolescents.
Circ J
; 86(1): 118-127, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615813
2.
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.
Lancet
; 393(10176): 1128-1137, 2019 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30853151
3.
Treatment change and coronary artery abnormality in incomplete Kawasaki disease.
Pediatr Int
; 62(7): 779-784, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219919
4.
ß2 microglobulin and lactate dehydrogenase are indices of different features of Mycoplasma pneumoniae-associated community-acquired lower respiratory tract infection for severity evaluation in children.
J Infect Chemother
; 25(12): 1007-1011, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31227380
5.
Characteristics of time-activity curves obtained from dynamic 11C-methionine PET in common primary brain tumors.
J Neurooncol
; 138(3): 649-658, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564749
6.
Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement.
Eur Heart J
; 37(31): 2490-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27026747
7.
Environmental risk factors for sudden infant death syndrome in Japan.
Eur J Pediatr
; 175(12): 1921-1926, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27664161
8.
Circulating platelet-neutrophil aggregates play a significant role in Kawasaki disease.
Circ J
; 79(6): 1349-56, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25787672
9.
Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).
Pediatr Int
; 62(10): 1135-1138, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33001522
10.
Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
Int Arch Allergy Immunol
; 164(2): 83-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24903098
11.
Bevacizumab treatment leads to observable morphological and metabolic changes in brain radiation necrosis.
J Neurooncol
; 119(1): 101-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24789256
12.
Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.
Lancet
; 379(9826): 1613-20, 2012 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22405251
13.
Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder.
Pediatr Int
; 54(1): 14-8, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22115193
14.
Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease.
Front Immunol
; 12: 640315, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34079539
15.
Kawasaki Disease and Vaccination: Prospective Case-Control and Case-Crossover Studies among Infants in Japan.
Vaccines (Basel)
; 9(8)2021 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451964
16.
Platelet vascular endothelial growth factor is a useful predictor for prognosis in Kawasaki syndrome.
Br J Haematol
; 148(2): 285-92, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19793253
17.
A severe form of Kawasaki disease presenting with only fever and cervical lymphadenopathy at admission.
J Pediatr
; 156(5): 786-91, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20097355
18.
An elevated value on drug-induced lymphocyte stimulation test for immunoglobulin is an immunological abnormality of Kawasaki disease.
Int Arch Allergy Immunol
; 153(1): 102-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20357491
19.
Risk factors for development of ventricular tachycardia in patients with ventricular premature contraction with a structurally normal heart.
J Arrhythm
; 36(1): 127-133, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32071631
20.
An elevated value of high mobility group box 1 is a potential marker for poor response to high-dose of intravenous immunoglobulin treatment in patients with Kawasaki syndrome.
Pediatr Infect Dis J
; 28(4): 339-41, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19238112